WALTHAM, Mass.— Trinity Life Sciences has announced the launch of its new Value Center of Excellence (COE), a strategic initiative aimed at enhancing Market Access and Health Economics and Outcomes Research (HEOR) outcomes by integrating health equity considerations into global value narratives.
Led by Mary Fletcher-Louis, Managing Director in Trinity’s Evidence, Value, Access & Pricing practice, the Value COE offers a unified approach that bridges market access strategy with rigorous HEOR methodologies. The center is designed to support life sciences companies through every step of the value journey, from evidence planning and value proposition development to dossier creation and payer engagement.
“As global health technology assessment (HTA) bodies increasingly factor health equity into their recommendations, it’s critical for life sciences companies to align their access strategies accordingly,” said Monica Martin de Bustamante, Senior Partner and Head of Advisory at Trinity. “Our Value COE helps ensure that health equity insights are seamlessly embedded into access materials, increasing their relevance and impact.”
The integration of HEOR and access perspectives allows the Value COE to craft compelling value stories that address both scientific rigor and payer expectations. Trinity’s approach emphasizes consistency across all value communication tools, which the company says is essential to achieving favorable pricing and market access for new therapies.
“Value work in life sciences should be driven by both HEOR and Access mindsets,” said Fletcher-Louis. “By combining these disciplines, Trinity’s Value COE builds differentiated value propositions that resonate across global markets.”
The launch of the Value Center of Excellence underscores Trinity Life Sciences’ broader commitment to advancing equitable healthcare access through innovative strategy and analytics.
